[The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities]
- PMID: 17682711
[The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities]
Abstract
Due to the increase in the number of immunosuppressive patients, an increase in the frequency of Candida albicans infections is recorded during the recent years. C. albicans strains can be grouped into three genotypes (genotypes A, B and C) by 25S intron analysis according to the presence of a transposable group-1 intron. Genotype A isolates were found to be associated with increased resistance to flucytosine. The aim of this study was to determine the genotypic distribution of C. albicans isolates and investigate the relationship between the genotypes and antifungal susceptibility patterns. Seventy clinical C. albicans isolates were included in the study. The strains were identified by API ID 32C (bioMerieux, France), and antifungal susceptibilities were determined by ATB Fungus 2 (bioMerieux, France) system. Following DNA extraction from the isolates, polymerase chain reaction (PCR) was performed as indicated in the literature. The genotypes were determined according to the size of the amplified PCR product. For the statistical analysis of the relationship between the genotypes and antifungal susceptibility patterns, Pearson's khi square and Fisher's exact tests were performed. Among the 70 strains investigated, 35 (50%) were found as genotype A, nine (12.9%) were genotype B and 26 (37.1%) were genotype C. Nystatin, miconazole and ketoconazole susceptibilities were significantly different among the genotypes, genotype B being more resistant to these agents (p values were 0.032, 0.035 and 0.035, respectively). When the susceptibility of the strains were compared according to the presence of the transposable intron, no significant difference was observed. There was also no statistically significant difference between the genotype distribution of the isolates and flucytosine, amphotericin B and econazole susceptibilities (p values were 0.357, 0.602 and 0.051, respectively). As a result, in order to clarify the resistance mechanisms of different genotypes of C. albicans isolates, more sophisticated and large-scale studies should be performed.
Similar articles
-
Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.Mycoses. 2009 Jan;52(1):24-8. doi: 10.1111/j.1439-0507.2008.01539.x. Epub 2008 May 21. Mycoses. 2009. PMID: 18498300
-
Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.J Clin Microbiol. 2001 Dec;39(12):4309-15. doi: 10.1128/JCM.39.12.4309-4315.2001. J Clin Microbiol. 2001. PMID: 11724837 Free PMC article.
-
[25S intron analysis followed by restriction enzyme digestion performed for genotyping Candida albicans isolates].Mikrobiyol Bul. 2012 Apr;46(2):257-65. Mikrobiyol Bul. 2012. PMID: 22639314 Turkish.
-
Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans.FEMS Yeast Res. 2006 Nov;6(7):987-98. doi: 10.1111/j.1567-1364.2006.00108.x. FEMS Yeast Res. 2006. PMID: 17042748 Review.
-
Biofilms of Candida albicans and their associated resistance to antifungal agents.Am Clin Lab. 2001 Aug;20(7):42-4. Am Clin Lab. 2001. PMID: 11570274 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Research Materials